NexGen Press® from GEA: one system, many application options

Oral solid dosage forms play a significant role in the healthcare industry today and will continue to do so in the future. According to the requirements of the pharmaceutical industry, modern tabletting systems must be energy-efficient, flexible and multifunctional for processing increasingly powerful active pharmaceutical ingredients. GEA provided the answer at ACHEMA 2022, where the machinery and equipment manufacturer and solution provider presented the new NexGen Press®, a new tablet press product line.

NexGen Press® combines the advantages of GEA's MODUL and PERFORMA rotary table press lines. The NexGen Press® line is not only a combination of existing technologies and available components, but a next generation tablet press for the pharmaceutical industry. It is therefore a state-of-the-art solution for a wide range of tableting applications. "The NexGen Press is an example of our approach to digitalization and modularization," explains Evelien Devroey, Strategic Business Manager, Pharma Solid Dosage at GEA Pharma & Healthcare. "By offering one machine with many applications, we are well prepared for the future," says Evelien Devroey.

"Modular design means that a spectrum of containment capabilities (from basic protection to OEB 5. OEB 5 means a load of less than 1 µg/m3.) is available on a single platform." It is also the first machine series compatible with both Wash-Offline (WOL) and Wet-In-Place (WIP) to meet a wide range of customer requirements. For example, the base model can be upgraded as needed to meet specific process requirements. Process requirements might include tableting two layers or different cleaning options to further reduce the risk of cross-contamination.

In addition, each machine is intuitive to operate and benefits from a back-to-basics design philosophy. As with all GEA tablet presses, occupational and product safety, robust functionality, support and after-sales service come as standard.